These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 2869482

  • 41. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC.
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p.
    Graziano SL, Cowan BY, Carney DN, Bryke CR, Mitter NS, Johnson BE, Mark GE, Planas AT, Catino JJ, Comis RL.
    Cancer Res; 1987 Apr 15; 47(8):2148-55. PubMed ID: 3030544
    [Abstract] [Full Text] [Related]

  • 44. Detection of amplified genomic sequences in human small-cell lung carcinoma cells by arbitrarily primed-PCR genomic fingerprinting.
    Okazaki T, Takita J, Kohno T, Handa H, Yokota J.
    Hum Genet; 1996 Sep 15; 98(3):253-8. PubMed ID: 8707290
    [Abstract] [Full Text] [Related]

  • 45. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP, Castillo SG, Nguyen CV, Hickey RC, Samaan NA.
    Anticancer Res; 1990 Sep 15; 10(1):189-92. PubMed ID: 2185686
    [Abstract] [Full Text] [Related]

  • 46. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y, Mannermaa A, Winqvist R, Kamel D, Poikonen K, Kiviniemi H, Pääkkö P.
    J Histochem Cytochem; 1994 Jun 15; 42(6):795-803. PubMed ID: 7910618
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
    Watanabe H, Takahashi T, Ueda R, Utsumi KR, Sato T, Ariyoshi Y, Ota K, Obata Y, Takahashi T.
    Cancer Res; 1988 May 01; 48(9):2544-9. PubMed ID: 2833350
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Transposition and amplification of oncogene-related sequences in human neuroblastomas.
    Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW.
    Cell; 1983 Dec 01; 35(2 Pt 1):359-67. PubMed ID: 6197179
    [Abstract] [Full Text] [Related]

  • 51. A novel somatic point mutation of the RET Proto-oncogene in tumor tissues of small cell lung cancer patients.
    Futami H, Egawa S, Tsukada T, Maruyama K, Bandoh S, Noguchi M, Yamaguchi K.
    Jpn J Cancer Res; 1995 Dec 01; 86(12):1127-30. PubMed ID: 8635999
    [Abstract] [Full Text] [Related]

  • 52. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor.
    Yander G, Halsey H, Kenna M, Augenlicht LH.
    Cancer Res; 1985 Sep 01; 45(9):4433-8. PubMed ID: 4028026
    [Abstract] [Full Text] [Related]

  • 53. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I, Mäkelä TP, Koskinen PJ, Saksela K, Alitalo K.
    Princess Takamatsu Symp; 1991 Sep 01; 22():307-18. PubMed ID: 1668890
    [Abstract] [Full Text] [Related]

  • 54. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines.
    Johnson BE, Makuch RW, Simmons AD, Gazdar AF, Burch D, Cashell AW.
    Cancer Res; 1988 Sep 15; 48(18):5163-6. PubMed ID: 2842046
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Amplification units containing human N-myc and c-myc genes.
    Kinzler KW, Zehnbauer BA, Brodeur GM, Seeger RC, Trent JM, Meltzer PS, Vogelstein B.
    Proc Natl Acad Sci U S A; 1986 Feb 15; 83(4):1031-5. PubMed ID: 3006024
    [Abstract] [Full Text] [Related]

  • 57. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W, Sawai S, Hanawa T, Ishida H, Matsui T, Kosaba S, Watanabe S, Hatakenaka R, Matsubara Y, Funatsu T.
    Gan To Kagaku Ryoho; 1993 Apr 15; 20(6):824-7. PubMed ID: 8098200
    [Abstract] [Full Text] [Related]

  • 58. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK, Sarafoff M, Kerler R, Rabes HM.
    Cancer Res; 1989 Dec 01; 49(23):6781-7. PubMed ID: 2684400
    [Abstract] [Full Text] [Related]

  • 59. Mistletoe lectin inhibits growth of Myc-amplified small-cell lung cancer.
    Shatat MA, Gauthier B, Yoon S, Yuan E, Yang P, Narla G, Dowlati A, Lee RT.
    Cancer Med; 2023 Apr 01; 12(7):8378-8387. PubMed ID: 36562288
    [Abstract] [Full Text] [Related]

  • 60. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H, Dang CV.
    Cancer Res; 2000 Jan 01; 60(1):143-9. PubMed ID: 10646866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.